<DOC>
	<DOCNO>NCT02161822</DOCNO>
	<brief_summary>Statins widely use lipid-lowering agent low cardiovascular risk favorable safety profile . In recent vitro study , addition simvastatin chemoradiotherapy 5-FU show synergistic anticancer effect various colon cancer cell ( unpublished data ) . So planned study investigate synergistic effect simvastatin combine capecitabine radiotherapy locally advanced rectal cancer patient .</brief_summary>
	<brief_title>Capecitabine Plus Simvastatin Locally Advanced Rectal Cancer Patients</brief_title>
	<detailed_description>1 . Primary Objective : pathologic complete response rate 2 . Secondary Objectives : 1. rate sphincter-sparing surgical procedure 2. rate R0 resection 3. disease-free survival 4. overall survival 5. pattern failure 6. safety toxicity 7. lipid lower effect simvastatin</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Histologicallyconfirmed adenocarcinoma rectum AJCC/UICC clinical stage cT34 cN+ age â‰¥ 20 year ECOG performance status 01 No prior chemotherapy radiotherapy Adequate major organ function follow : Written inform consent Willing able comply protocol Prior statins therapy within 1year date study entry Uncontrolled severe cardiovascular disease : New York Heart Association class III IV heart disease Unstable angina myocardial infarction within past 6 month History significant ventricular arrhythmia require medication antiarrhythmic significant conduction system abnormality . Past current history ( within last 5 year prior treatment start ) malignancies except rectal cancer ( Patients curatively treat basal squamous cell carcinoma skin situ carcinoma cervix eligible ) Uncontrolled systemic illness DM , hypertension , hypothyroidism infection Pregnant nursing woman ( woman reproductive potential agree use effective contraceptive method ) Patients CPK &gt; 5 X ULN baseline Concomitant use clarithromycin , erythromycin , itraconazole , ketoconazole , nefazodone , telithromycin , gemfibrozil , cyclosporine , danazol , amiodarone , verapamil</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>locally advanced rectal cancer , neoadjuvant chemoradiation</keyword>
</DOC>